CEP290 anticorps (Internal Region)

N° du produit ABIN570714

Détail du produit anti-CEP290 anticorps

Antigène: CEP290 (Centrosomal Protein 290kDa (CEP290))

Épitope: Internal Region

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp CEP290 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC)

Fonction: CEP290

Séquence: RNSKHLKQQQ YRAEN

Specificité: Despite similarity of the immunizing peptide with the mouse protein, this antibody was demonstrated to weak for mouse Cep290.

Réactivité croisée: Humain

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Verified

Immunogène: Peptide with sequence C-RNSKHLKQQQYRAEN , from the internal region of the protein sequence according to NP_079390.3.

Isotype: IgG

Information d'application

Indications d'application:

Immunohistochemistry: Paraffin embedded Human Prostate. Recommended concentration: 5-7 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:128000.

Commentaires:

Immunocytochemistry: Formaldehyde-fixed cell lines derived from Prostate Cancer and from Breast Cancer show typical centrosomal staining. Recommended concentration: 2-3ug/ml.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur CEP290

Antigène: CEP290 (Centrosomal Protein 290kDa (CEP290))

Autre désignation: CEP290 (CEP290 Produits)

Synonymes: anticorps ct87, anticorps mks4, anticorps rd16, anticorps bbs14, anticorps jbts5, anticorps jbts6, anticorps lca10, anticorps nphp6, anticorps slsn6, anticorps sh11ag, anticorps MGC81471, anticorps 3h11ag, anticorps RGD1311640, anticorps BC004690, anticorps Nphp6, anticorps b2b1454Clo, anticorps b2b1752Clo, anticorps im:7145703, anticorps im:7147820, anticorps 3H11Ag, anticorps BBS14, anticorps CT87, anticorps JBTS5, anticorps LCA10, anticorps MKS4, anticorps NPHP6, anticorps POC3, anticorps SLSN6, anticorps centrosomal protein 290, anticorps centrosomal protein 290 L homeolog, anticorps centrosomal protein 290kDa, anticorps CEP290, anticorps cep290.L, anticorps cep290, anticorps Cep290

Sujet: CEP290, centrosomal protein 290 kDa, 3H11Ag, BBS14, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, monoclonal antibody 3H11 antigen, nephrocytsin-6, prostate cancer antigen T21

ID gène: 80184, 216274

NCBI Accession: NP_079390

Pathways: cAMP Metabolic Process, M Phase